Results 51 to 60 of about 52,940 (69)

A Review of the Totality of Evidence in the Development of ABP 798, A Rituximab Biosimilar

Immunotherapy, 2022
Dietger Niederwieser, Stanley B Cohen, Sonya G Lehto   +2 more
exaly  

Non-clinical similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2021
Helen J Mcbride, Lu Min, Scott Kuhns
exaly  

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis

Clinical Rheumatology, 2020
David Chien
exaly  

Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product

Biologicals, 2020
Scott Kuhns, Mats Wikström, Jennifer L Liu   +2 more
exaly  

A Randomized, Double‐Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical Pharmacology in Drug Development, 2020
David Chien
exaly  

Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product

Targeted Oncology, 2020
Dietger Niederwieser, Cecily J Forsyth, Alessandra Tucci   +2 more
exaly  

Interpretation of 798: Changes in Power of Representation and Sustainability of Industrial Landscape

Sustainability, 2015
Juncheng Dai, Huasheng Zhu
exaly  

Negative chronotropic effect of a novel class III antiarrhythmic drug, UK‐68,798, devoid of β‐blocking action on isolated guinea‐pig atria

British Journal of Pharmacology, 1991
Tao Yang
exaly  

Solvatochromic dye LDS 798 as microviscosity and pH probe

Physical Chemistry Chemical Physics, 2017
Marlius Castillo, Micheline Bejjani, Zhangatay Nurekeyev   +2 more
exaly  

Marker-assisted introgression of the major bacterial blight resistance genes, Xa21 and xa13, and blast resistance gene, Pi54, into the popular rice variety, JGL1798

Molecular Breeding, 2019
M Sheshu Madhav
exaly